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Coordinate regulation of canine glomeruli and adrenal angio- The angiotensin II type 1 (AT1) receptor is involved
tensin receptors by dietary sodium manipulation. in the regulation of arterial blood pressure and mediates
Background. This study evaluated the effects of dietary so- most physiological effects of angiotensin II (Ang II) suchdium manipulation in dogs on the regulation of canine angio-
as stimulation of aldosterone secretion, vasoconstriction,tensin receptors (cAT1 and cAT2) in the kidney and adrenal.
regulation of water intake, renal blood flow, glomerularMethods. Isolated glomeruli and membranes from renal me-
dulla and the adrenal gland were used in radioligand binding filtration, and sodium and water reabsorption. AT1 re-
assays from two groups of dogs: dogs maintained on low-sodium ceptors have also been implicated in the pathogenesis
diet for two weeks followed by a high-sodium diet for two weeks
of various types of arterial hypertension [1, 2], although(H), and dogs were maintained on the reverse schedule (L).
their exact role and mechanism of involvement areResults. Analysis of the binding data showed that dietary
sodium manipulation had no significant effects on cAT1 and largely unknown. Factors that influence AT1 receptor
cAT2 receptor binding affinities in glomeruli, renal medulla, regulation include dietary sodium, angiotensin-convert-
and adrenal tissues. In contrast, dietary sodium loading induced ing enzyme (ACE) inhibitors, renal hypoperfusion, re-a marked increase in cAT1 receptor expression in both the duced renal mass, thyroid dysfunction, renal glomerularglomeruli and adrenal compared with receptor expression in
disease, acute unilateral ureteral obstruction, and aorticsalt-restricted animals [H/L ratio: glomeruli (1.5), renal me-
dulla (1.1), adrenal (1.6)] that inversely correlated with the coarctation. Ang II helps maintain renal excretory func-
activity of the plasma renin angiotensin system. Conversely, tion under extreme conditions such as hemorphagic hy-
adrenal cAT2 receptor expression was regulated in an inverse potension, dehydration, and renal artery stenosis [3]. Themanner in the H and L animal groups [H/L ratio: 0.7].
AT1 receptor is found in most tissues, including the vesselConclusions. This study demonstrates that renal glomerular
and adrenal AT1 receptors in the dog are coordinately down- wall, brain, lung, adrenal, liver, and kidney.
regulated by dietary sodium restriction compared with sodium A powerful determinant of rat AT1 (rAT1) receptor
loading, which is distinctly different from the reciprocal regula- regulation is dietary sodium. Rat glomerular AT recep-
tion observed for rat AT1 receptors in these tissues. Collec- tors down-regulate during sodium depletion and duringtively, these data suggest that postreceptor events in dogs are
administration of high doses of an Ang II infusion anddeterminants of the aldosterone response observed during so-
dium restriction. These findings have important implications up-regulate during sodium loading [4, 5]. These actions
for the regulation of the renin-angiotensin system in humans, are analogous to those in extrarenal smooth muscle. The
and suggest that coordinate regulation of AT1 receptors in the administration of the ACE inhibitor captopril preventsadrenal and glomeruli represent a negative feedback mecha-
glomerular rAT receptor down-regulation, indicatingnism that when functioning normally prevents fluctuations of
arterial blood pressure and development of arterial hyperten- that this effect is mediated by Ang II. The ability of Ang
sion in response to changes in dietary sodium. II to modulate glomerular hemodynamics is reduced dur-
ing sodium depletion and enhanced during sodium load-
ing [4]. Thus, these directional changes in rAT receptor
expression correlate with the physiological changes in
glomerular hemodynamics. In contrast, sodium deple-Key words: kidney, dog, AT1 receptor, arterial hypertension, aldoste-
rone, renin-angiotensin system, sodium handling. tion in rats up-regulates rAT1 receptor expression in
adrenal glomerulosa cells [6]. Thus, a reciprocal mecha-Received for publication August 18, 2000
nism of glomerular and adrenal receptor regulation ex-and in revised form November 22, 2000
Accepted for publication November 29, 2000 ists in the rat kidney during changes in Ang II concentra-
tion. These observations in rats have been attributed toÓ 2001 by the International Society of Nephrology
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two cloned rAT1 receptor subtypes (rAT1a and rAT1b) quickly cleaned of fat and rinsed with ice-cold phosphate
buffered saline (PBS), they were immersed in liquid ni-[7, 8], which are differentially regulated by dietary so-
dium [9]. trogen and kept at 2808C until further analysis.
The dog is an excellent animal model for investigating
Hormone assaysthe physiology and pathophysiology of the human renin-
angiotensin system (RAS). As found in humans, the dog The dogs were sacrificed by an overdose of pentobar-
bital. Approximately 10 mL of blood were collected inhas only one isoform of the AT1 receptor. In fact, only
one AT1 receptor isoform has been identified in all other the presence of ethylenediaminetetraacetic acid (EDTA;
5 mmol/L) for determination of plasma renin activitymammalian species cloned to date [10]. Thus, mecha-
nisms of AT1 receptor regulation are not complicated (PRA), Ang II, aldosterone, and corticosterone levels.
PRA and Ang II were assayed as previously describedby the differential regulation of AT1 isoforms that are
observed in rats and mice. There is also a wealth of [13]. Plasma aldosterone concentrations were measured
by radioimmunoassay after extraction with methyleneinformation on the dog RAS because of extensive inves-
tigations into canine renal physiology and cardiovascular chloride and fractionation by LH-20 chromatography
[14]. Plasma corticosterone concentrations were alsoregulation [11]. Furthermore, dogs are well suited for in
vivo studies with positron emission tomography (PET) measured by radioimmunoassay according to published
procedures [15].because of the size and geometry of their organs. We
are currently using the dog to image canine AT1 (cAT1)
Kidney glomeruli isolationreceptors in the kidney by PET and have found a strong
correlation between PET and biochemical measure- The kidneys were sliced along the corticomedullary
axis to separate the cortex from the medulla. The glomer-ments of renal cAT1 receptor regulation under a variety
of conditions [12]. Thus, studying cAT1 receptor regula- uli were then isolated from the cortex in ice-cold PBS.
Cortical tissue was initially sieved through a wire meshtion in the dog is likely to lead to human studies investi-
gating the role of the RAS in various types of arterial (150 mm #100, wire cloth-stainless steel, diameter 0.0059
inches; Small Parts Inc., Miami, FL, USA) and collectedhypertension, since PET imaging is a very promising
tool that can be used to elucidate normal and abnormal in a beaker containing PBS. The cortical solution was
passed through two stacked sieves. After the glomeruliresponses of the human AT1 receptor under physiologi-
cal and pathophysiological conditions. were passed through the top sieve (180 mm #80; 0.007
inch mesh; #170 Tyler), they were collected on the topSince studies examining AT receptor regulation have
been mainly characterized in rats and mice, it is not well of the bottom sieve (90 mm #170; 0.0035 inch mesh; #200
Tyler). The isolated glomeruli were centrifuged at 250 3known how the AT1 receptor is regulated by the RAS
in species possessing a single AT1 receptor subtype. We g for 10 minutes at 48C. The pellet was resuspended in
ice-cold PBS and washed three times in PBS by centrifu-examined the effect of dietary sodium manipulation on
cAT1 receptor expression in order to gain a greater un- gation at 250 3 g for 10 minutes at 48C. The washed
glomeruli were resuspended at final concentrations ofderstanding of the role that cAT1 receptors play in renal
responsiveness to changes in the RAS in a species that 0.5 to 1.0 mg protein/mL in PBS and then immediately
stored at 2808C.may be more pertinent to humans than rodents.
Membrane preparation
METHODS
Renal medullary tissue was homogenized for 20 sec-
Animal protocol onds using a Brinkman polytron (Model PT 10/35) with
a Powerstat variable autotransformer (at setting #70) inBeagles weighing approximately 20 kg were divided
into two groups. Animals in group H were kept for two 30 volumes of buffer A (50 mmol/L Tris-HCl, 1 mmol/L
EDTA buffer, pH 7.4) supplemented with proteinaseweeks (6 per group) on a low-sodium diet (10 mEq NaCl/
day) followed by two weeks on a high-sodium diet (300 inhibitors (final concentrations: 0.1 mmol/L phenylmeth-
ane-sulfonyl fluoride, 10 mg/mL leupeptin, 0.24 U/mLmEq NaCl/day; Hills Pet Products Inc., Topeka, KS,
USA). Animals in group L were kept on the opposite aprotinin, 10 mg/mL antipain) at 48C. Adrenal tissue was
homogenized with 10 strokes in a glass homogenizer inregime, starting with high-salt diets for two weeks fol-
lowed by low-salt diets for two weeks. This dietary regi- 40 volumes of buffer A. The homogenate was centrifuged
at 500 3 g for 10 minutes at 48C. The supernatant wasmen was selected to improve reproducibility between
animals within each animal group. At the end of the four- filtered through a 180 mmol/L sieve (#80, 0.007 inch)
and centrifuged at 2500 3 g for 10 minutes at 48C. Theweek period, the dogs were sacrificed by an overdose
of pentobarbital, and blood samples were collected for resultant supernatant was centrifuged at 100,000 3 g for
30 minutes. The pellet was washed with buffer A bymeasurement of plasma renin, Ang II, aldosterone, and
corticosterone. After the kidneys and adrenals were centrifuging at 100,000 3 g for 30 minutes. The washed
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pellet was resuspended in buffer A at approximately 1 value of 0.85 or greater was the criterion used for data
acceptability.mg protein/mL and immediately stored at 2808C.
Protein assays Statistical analysis
All results are expressed as mean values 6 SEM, andProtein concentrations of isolated glomeruli and med-
ullary and adrenal membranes were determined by the differences between the low-salt (L) and high-salt (H)
animal groups were analyzed statistically using one-wayBradford method [16] using bovine serum albumin
(BSA) as the standard (Bio-Rad Laboratories, Rich- analysis of variance (ANOVA) followed by post hoc com-
parisons via the Student–Newman–Keuls test or an un-mond, CA, USA).
paired t-test. Statistical significance was defined as P , 0.05.
Angiotensin II receptor binding studies
Medullary and adrenal membranes were sonicated for
RESULTS
five seconds with a Sonifer cell disrupter immediately
Effect of dietary sodium manipulation on PRA andbefore use in binding assays. Unless otherwise indicated,
plasma levels of Ang II, aldosterone, and cortisol5 mg of glomeruli, 60 mg of medullary membranes, and
5 mg of adrenal membranes were incubated for one to To confirm the effectiveness of dietary sodium manip-
ulation in dogs, we measured PRA (Fig. 1A), Ang IIthree hours at room temperature with 125I-[Sar1,
Ile8]Ang II (Peptide Radioiodination Center, Pullman, (Fig. 1B), aldosterone (Fig. 1C), and cortisol (Fig. 1D).
Sodium deprivation markedly increased plasma levels ofWA, USA) in 0.3 mL of buffer B (100 mmol/L NaCl,
10 mmol/L Na2HPO4, 5 mmol/L EDTA, pH 7.4) supple- renin activity (9.1-fold), Ang II (7.8-fold), and aldoste-
rone (31-fold) compared with the sodium-loaded group.mented with 0.1% BSA. Bound tracer was rapidly sepa-
rated from unbound tracer by washing the filters four No significant differences were found in plasma cortisol
levels between the low- and high-salt groups, indicatingtimes with ice-cold PBS using a Brandel vacuum har-
vester (Model M-24; Gaithersburg, MD, USA). Radioac- that no marked differences in the levels of stress occurred
between the two animal treatment groups. Furthermore,tivity was measured in a gamma counter (Packard, Co-
bra, Downers Grove, IL, USA). Preincubation of glass there were no significant differences in body weight or
mean arterial pressure between these two groups at thefiber filters with 0.1% bovine serum albumin for one
hour was used to reduce nonspecific absorption of the end of the experiment (data not shown). These results
are consistent with previous reports demonstrating thatradioligand to the filters. All determinations were per-
formed in triplicate. Nonspecific binding was defined as dietary sodium restriction activates the plasma RAS by
increasing PRA and plasma Ang II and aldosterone lev-the amount of radioligand bound in the presence of 200
nmol/L Ang II, and specific binding was defined as the els in rodents [9] and dogs [17], and is relevant to clinical
conditions in which the RAS is activated such as reno-total radioligand bound minus nonspecific binding.
Competition assays. Isolated glomeruli and medullary vascular hypertension and heart failure [18, 19].
and adrenal membranes were incubated with 0.25 nmol/L
Time course and dose response of AT receptor(,300,000 cpm) of 125I-[Sar1,Ile8]Ang II (Peptide Radio-
binding in glomeruli, renal medulla, andiodination Center) and indicated concentrations of com-
adrenal membranespetitor ligands. Inhibitory constants (IC50) for competi-
tors were determined by nonlinear regression analysis In initial experiments, we optimized the binding of the
AT receptor antagonist 125I-[Sar1,Ile8]Ang II to canineusing the program KaleidaGraph (Synergy Software,
Reading, PA, USA). glomeruli and medullary and adrenal membranes in
terms of the time course to reach steady state (Fig. 2A)Saturation analysis. Isolated glomeruli and medullary
and adrenal membranes were incubated with increasing and the dose response of increasing protein (Fig. 2B).
A time course of 125I-[Sar1,Ile8]Ang II binding to isolatedconcentrations of 125I-[Sar1, Ile8]Ang II (0.05 to 4 nmol/L).
To determine the changes in cAT1 receptor expression, glomeruli and medullary membranes at room tempera-
ture revealed that maximal specific binding was reachedsaturation analysis was performed in the presence of 10
mmol/L PD-123,319 (AT2 receptor antagonist). Accord- by one hour and was stable thereafter for up to six hours.
In comparison, AT receptor binding in adrenal mem-ingly, to determine the changes in cAT2 receptor expres-
sion, saturation analysis was performed in the presence branes reached steady state by three hours. Incubation
of increasing concentrations of protein demonstratedof 20 mmol/L losartan (AT1 receptor antagonist). AT
receptor densities (Bmax) and affinities (Kd) were analyzed that 125I-[Sar1,Ile8]Ang II specific binding was linearly
related to the protein concentration in the range of 5 toby Scatchard analysis using PRISM, a nonlinear regres-
sion analysis program (GraphPad Software, Inc. San 20 mg isolated glomeruli, 5 to 25 mg renal medullary
membranes, and 5 to 30 mg adrenal membranes. Conse-Diego, CA, USA). A linear regression was performed
on the amount bound versus bound/free ligand. An r2 quently, all further binding experiments were performed
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Fig. 1. Effect of dietary sodium manipulation on parameters of the renin-angiotensin system (RAS). Blood was removed from animals in the
High salt (h) and Low salt (j) groups and analyzed for plasma levels of renin (A), Ang II (B), aldosterone (C), and corticosterone (D). Data
are expressed as the means 6 SEM from assays performed in triplicate. N 5 4 per group.
at room temperature for three hours using 5 mg of iso- was the cAT1 receptor. That is, the AT1 receptor antago-
nists SK-31,080 and losartan competed for nearly all thelated glomeruli, 50 mg renal medullary membranes, and
5 mg of adrenal membranes. Under these conditions, specific glomeruli (Fig. 3A), renal medullary (Fig. 3B)
binding and for the majority of the adrenal binding (Fig.total 125I-[Sar1,Ile8]Ang II binding to isolated glomeruli
and renal medullary and adrenal membranes was ,10% 3C). However, there was a significant population of cAT2
receptors present in the adrenal (Fig. 3C), as evidencedof the total ligand concentration in the binding assay.
Since the free concentration of radioligand was approxi- by the ability of the type 2 AT receptor antagonist PD-
mately equal to the concentration added, ligand deple- 123,319 to compete and the inability of the two AT1
tion was negligible during the binding reaction. The bind- antagonists to compete fully for radioligand binding to
ing assay followed the law of mass action. Furthermore, the receptor. Analysis of these competition curves re-
the nonspecific binding component of 125I-[Sar1,Ile8]Ang vealed that the percentages of cAT1 receptors in the
II binding represented approximately 2, 2, and 5% of total glomerular, renal medulla, and adrenal AT receptor
the total binding at 500 pmol/L (a concentration near population were 98, 97, and 75%, respectively. These
the Kd) and 4, 1, and 10% of the total binding at 50 calculations of receptor subtype distribution are supported
pmol/L for glomeruli and medullar and adrenal mem- by the observations that AT1/AT2 receptor-balanced af-
branes, respectively. finity peptide (Ang II) and nonpeptide (L-163,017) li-
gands were able to compete for 100% of the specific
Analysis of AT receptor subtype distribution in dog binding. A comparison of ligand affinities revealed simi-
glomeruli and medulla and adrenal membranes lar IC50 values for Ang II peptide and nonpeptide ligands
among the tissues (Table 1). Our results also confirmCompetition radioligand binding assays showed that
the predominant receptor subtype in all three tissues earlier reports showing that the nonpeptide losartan has
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Fig. 2. 125I-[Sar1,Ile8]Ang II binding to kidney and adrenal canine angio-
tensin II subtype 1 (cAT1) receptors. (A) Time course. Isolated kidney
glomeruli (d) and membranes prepared from renal medulla (j) and
the adrenal gland (s) were incubated for different times with 500
pmol/L 125I-[Sar1,Ile8]Ang II at 278C. Values are the means 6 SEM
from three independent experiments performed in duplicate. (B) Dose
response curve. Isolated kidney glomeruli (d) and membranes prepared
from the renal medulla (j) and adrenal gland (s) were incubated
with 500 pmol/L 125I-[Sar1,Ile8]Ang II and increasing concentrations of
membranes ranging from 5 to 30 mg protein per sample for 120 minutes
at 278C. Values are the means 6 SEM from three independent experi-
ments performed in triplicate. Fig. 3. Competition binding profiles of angiotensin ligands for dog AT
receptors expressed in kidney and adrenal tissues. The binding profiles
of Ang II (s), L-163,017 (m), SK31080 (d), losartan (h), and PD-
123,319 (r) are shown for isolated kidney glomeruli (A), and mem-
branes prepared from renal medulla (B) and the adrenal gland (C).tenfold lower affinities toward the AT1 receptor in dogs Samples were incubated with 500 pmol/L 125I-[Sar1,Ile8]Ang II and in-
[10] than it does in rats [20, 21], humans [21, 22], and creasing concentrations of unlabeled competitor ligands. The x axis
represents the log concentration (mol/L) of unlabeled competitor li-sheep [23].
gands, and the y axis represents the binding expressed as a percentage
of the specific binding obtained in the absence of competitor. Each
Effect of dietary sodium manipulation on AT point represents the mean of specific binding data from three separate
experiments carried out in triplicate. (Inset) The binding profile of PD-receptors in glomeruli and medulla and
123,319 for adrenal membranes under conditions in which all the cAT1adrenal membranes
receptors are blocked with losartan (10 mmol/L) is shown.
Saturation curves from 0.025 to 2.0 nmol/L of 125I-[Sar1,
Ile8]Ang II revealed a saturable and single population
of high-affinity cAT1 receptors in glomeruli (Fig. 4A)
and renal medulla (Fig. 4B) and adrenal (Fig. 4C) tissues.
In the adrenal, a single population of cAT2 receptors
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Table 1. Binding affinities (IC50, nmol/L) for angiotensin II type 1 The cAT1 receptor [10] is approximately 95% identical(AT1) receptor ligands to the rAT1 receptor at the amino acid level [24]. How-
Tissue Ang II SK-31,080 Losartan PD-123,319 L-163,017 ever, the affinity for losartan and another related bi-
Glomeruli 32610 13.0765 560640 .10,000 6.160.6 phenylimidazole nonpeptide, SK-31,080, is significantly
Medulla 1362 4.460.3 4106100 .10,000 19610 reduced at the dog receptor (Fig. 3 and Table 1) com-
Adrenal 4.860.2 6.3762 590670 3063a 5.661
pared with the rAT1 receptor [25]. Previously, we identi-
IC50 values were obtained from competition binding curves (as in Fig. 3) per- fied 13 residues in the transmembrane domains of theformed three times in triplicate using the program KaleidaGraph and expressed
as the mean 6 SEM. rAT1 receptor that were critical for losartan binding
a IC50 values were obtained from competition binding curves performed three [26, 27]. We took advantage of the fact that the amphib-times in triplicate under conditions in which the AT1 receptor was blocked (10
mmol/L losartan) and expressed as the mean 6 SEM ian Xenopus xAT receptor binds Ang II with affinities
similar to mammalian AT1 receptor but has very low affin-
ity toward losartan. Using site-directed mutagenesis, we
created an xAT mutant receptor that bound losartanwas also present (Fig. 4D). No significant differences
with affinities that were equivalent to the rAT1 receptors.were found in the apparent dissociation constants of
This gain-of-function amphibian mutant had 13 residuescAT1 and cAT2 receptors between the low- and high-
exchanged for the rAT1 receptor counterpart aminosalt groups in all three tissues examined (Table 2). In
acids [27]. Ala163 is the only amino acid of these identifiedthe kidney, dietary sodium manipulation did not have a
residues that is different in the cAT1 receptor. In the dog,significant effect on Bmax values in the renal medulla,
residue 163 is a leucine. In the rAT1 receptor, mutationwhereas sodium loading significantly increased by 1.4-
of this residue to serine (as is found in the amphibianfold, cAT1 receptor Bmax values in the glomeruli com-
receptor) causes a tenfold reduction in the affinity of thepared with sodium-restricted animals (Fig. 5). In the
receptor toward losartan [26]. In the ferret AT1 receptor,adrenal membrane, sodium loading significantly in-
substitution of threonine at position 163 with an Alacreased cAT1 receptors by 1.6-fold compared with the
increased the affinity for losartan by ninefold [28]. Wesodium-restricted group, while cAT2 receptors under the
therefore predict that changing this residue to an alaninesame conditions were regulated in a reciprocal manner
in the cAT1 receptor would markedly increase receptor(Fig. 5). cAT2 receptors were significantly higher 1.4-fold
affinity toward losartan and SK-31,080 as well as otherin the low-salt compared with the high-salt group. The
members of this class of AT1 receptor nonpeptide ligands.consequence of this inverse receptor regulation is that
Collectively, these data support the idea that Ala163 is adietary sodium manipulation did not reveal any signifi-
key binding determinant of the biphenylimidazole classcant differences in total AT receptor expression in the
of nonpeptides in the AT1 receptor.adrenal membrane (data not shown).
One of the main target organs for mammalian Ang II
action is the kidney [11, 29]. As found in mice, rats, and
DISCUSSION humans [21, 30], the receptor population in the canine
kidney is predominantly AT1 (Fig. 3). Major renal actionsIn the present study, we modified a radioligand binding
assay for the high specific activity AT receptor antagonist of Ang II are mediated through AT1 receptors located on
glomerular mesangial cells [30, 31]. Activation of these125I-[Sar1,Ile8]Ang II in order to quantitate glomeruli, re-
nal medulla, and adrenal cAT receptor regulation in the glomerular receptors leads to a decrease in glomerular
filtration rate [11]. Our studies are consistent with thedog. Under the assay conditions employed, only 5 to 10
mg protein per sample were needed for cAT1 receptor known hemodynamic effects of dietary sodium manipu-
lation. The ability of Ang II to modulate glomerular hemo-analysis in isolated glomeruli and adrenal membranes,
and only 60 mg protein were needed for renal medullary dynamics is reduced during sodium depletion and en-
hanced during sodium loading [4]. Thus, the directionalmembranes. Thus, it was possible to quantitate cAT re-
ceptor affinities and number in isolated glomeruli and changes observed in cAT1 receptor expression in glome-
ruli but not in renal medullary membranes correlate within renal medullary and adrenal membranes from one
dog. Under these conditions, less than 10% of the total the physiological changes in cAT receptor action.
In the adrenal, 30% of the cAT receptor population125I-[Sar1,Ile8]Ang II concentration was bound, and the
binding of radioligand to these tissues was shown to are AT2, and 70% are AT1 (Fig. 3). Thus, the observed
cAT receptor population distribution in the dog adrenalbe rapid, saturable, and dependent on the membrane
protein concentration (Fig. 2). Saturation curves from is similar to the findings in rodents and humans [21, 30].
Although AT2 receptor expression is down-regulated10 to 800 pmol/L of 125I-[Sar1,Ile8]Ang II revealed a single
population of high-affinity AT receptors in each of these after birth in most tissues, including the kidney [32], AT2
receptors are still detectable and regulated under sometissues (Fig. 4). These results demonstrate that glomeruli
and the adrenal membrane are rich sources of cAT1 pathophysiological conditions such as myocardial in-
farction [33]. While less is known about AT2 receptorreceptor expression.
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Fig. 4. Saturation analysis of dog AT receptors expressed in kidney and adrenal tissues. Saturation curves of AT receptors for isolated kidney
glomeruli (A), and membranes prepared from renal medulla (B) and the adrenal gland (C and D). Samples were incubated with increasing
concentrations of 125I-[Sar1,Ile8]Ang II in the presence of saturating concentrations of the AT2 receptor blocker PD-123,319 in the presence and
absence of 200 nmol/L Ang II. Symbols are: (j high salt; (m) low salt. The x axis represents the concentration (nmol/L) of [Sar1,Ile8]-Ang II, and
the y axis represents the percentage specific binding. Each point represents the mean of specific binding data from three separate experiments
carried out in duplicate. (Insets) Scatchard plots from saturation binding data are shown.
function compared with the AT1 receptor, studies suggest
that AT2 receptors in the adrenal mediate apoptosis dur-
ing human fetal adrenal gland development [34], and
Table 2. Effect of dietary sodium manipulation on adrenal and
some studies suggest that AT2 receptors play a role inkidney AT receptor binding affinities [Kd (nmol/L)]
mediating catecholamine secretion from the adrenal me-
Tissue High salt diet Low salt diet
dulla [35]. In other tissues, AT2 receptors are linked to
Glomeruli AT1 1.260.2 0.6060.1 cell proliferation and differentiation [36] and in tissueMedulla AT1 1.360.4 0.7360.4
remodeling or repair [37, 38]. Therefore, it will be inter-Adrenal AT1 0.1260.005 0.1260.01
Adrenal AT2 0.660.1a 0.4760.03a esting to explore the physiological significance of the
Binding affinities were obtained from saturation binding curves (as in Fig. 4) regulation of adrenal cAT2 receptors. In this regard, AT2
performed three times in duplicate using the program PRISM and expressed as
receptors often have a counterbalancing role to AT1, andthe mean 6 SEM.
a Binding affinities were obtained from saturation binding curves performed thus the reciprocal regulation of adrenal cAT2 receptorsthree times in duplicate under conditions in which the AT1 receptor was blocked
(10 mmol/L losartan) and expressed as the mean 6 SEM compared with cAT1 in response to dietary sodium ma-
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losa [42, 43]. Thus, clearly there are differences in the
sodium regulation of rat and dog adrenal AT1 receptors,
as consistently observed that sodium depletion decreased
AT1 receptor number in the canine adrenal compared
with sodium loading (Figs. 4 and 5). These findings in
dogs are similar to findings in monkeys in which dietary
sodium restriction was shown to decrease adrenal AT
receptor expression [44]. The fact that dietary sodium
restriction in the dog leads to increased release of aldo-
sterone [17] and 18-hydroxylase activity [45], a key en-
zyme in the aldosterone biosynthetic pathway, suggests
that postreceptor events such as increased 18-hydroxy-
lase activity are important determinants in dogs and pri-
mates [44] to control adrenal sensitivity to Ang II. Fur-
thermore, the existence of spare adrenal cAT1 receptors
Fig. 5. Shown are cAT1 and cAT2 receptor Bmax values calculated from could contribute to the lack of correlation between
Scatchard plots for isolated kidney glomeruli and membranes prepared changes in receptor number and receptor action in these
from renal medulla and the adrenal gland in the high-salt (H; h) and
higher species. While no dramatic differences betweenlow-salt (L; j) animal groups. Data are expressed as the means 6 SEM
of Bmax values determined from Scatchard plots as in Figure 4. N 5 6 days 4 and 14 on dietary sodium regulation of rodent
per group. adrenal AT receptors were observed, it is possible that
the time to reach sodium depletion and sodium loading
is different between rodents and higher species. This
possibility will be addressed in future studies by examin-nipulation may be an important counter regulatory
ing the time course of adrenal and kidney cAT receptormechanism in blood pressure control.
regulation by dietary sodium manipulation.In rats, the two rAT1a and rAT1b receptor isoforms are
The molecular mechanisms of sodium regulation ofdifferentially regulated by dietary sodium. We previously
cAT1 receptors remains to be defined. Furthermore, thefound in the brain that dietary sodium deprivation reduced
possibility of differential AT receptor regulation in dif-the expression of rAT1a mRNA under the same conditions ferent compartments within the glomeruli and adrenalin which rAT1b mRNA was increased [9]. The converse could be obscured by membrane binding studies of thewas also observed under sodium loading, suggesting that
glomeruli and whole adrenal, since AT receptors arerAT1a and rAT1b play unique roles in maintenance of located in several different locations within the glomer-fluid homeostasis. Both Du et al [39] and Sechi et al [40]
uli, including mesangial, juxtaglomerular (JG) cells, epi-
have observed differential regulation of the rAT1 mRNA thelial, endothelial, and smooth muscle cells, and AT
isoforms in the kidney, although their results differ. The receptors are located in the zona glomerulosa, zona fasci-
discrepancy between these studies is likely to be related culata, and the medulla within the adrenal. Thus, it will
to the stage of animal development, species, and/or be important in future studies to investigate by radioli-
method for detecting AT1 isoform mRNAs. The develop- gand in situ autoradiography local changes in AT recep-
ment of real-time polymerase chain reaction (PCR) will tor populations within these tissues. Increased renin in-
greatly benefit studies focusing on mechanisms of sodium duced by sodium depletion results in elevated circulating
regulation of rAT1a and rAT1b receptor regulation, since and/or local Ang II levels (Fig. 1). Thus, Ang II could
real-time PCR avoids the artifacts inherent in competi- modulate cAT1 gene expression by a negative feedback
tive PCR reactions. However, its important to note that mechanism through ligand mediated down-regulation of
post-transcriptional regulation of AT1 receptors may re- the AT1 receptors. Clearly, these regulatory mechanisms
sult in changes in mRNA levels that do not directly play an important role in control of vascular respon-
reflect changes in cell surface receptor number. siveness to Ang II and need to be investigated further
Douglas and Catt [6] and Aguilera, Hauger, and Catt in a species that more closely parallels the human. In
[41] were the first to demonstrate that dietary sodium this regard, the adrenal responsiveness to ACE inhibitors
restriction increases AT receptor number in the rat adre- is enhanced in hypertensive patients [46]. Thus, the
nal, which parallels the increased extent of Ang II-induced mechanisms regulating adrenal responsivity are clearly
aldosterone release. Since the advent of AT receptor different in rats and humans.
subtype-selective ligands, several investigators have re- In summary, we have used a modified radioligand
ported that dietary sodium restriction increases AT1 re- binding assay to quantitate AT receptor expression in
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